Published April 9, 2025 - We’re excited to share that Abselion is featured in the Spring 2025 issue of Innovations in Pharmaceutical Technology (IPT), highlighting the role of our Amperia system in advancing at-line protein quantification for biologics and viral...
Anne brings over 25 years of global commercial experience in the Life Sciences, Healthcare and Cell Therapy arenas.
When Abselion was founded in 2018 (at that time under the name HexagonFab), we did not set out to change the world.
Dr. Ruizhi Wang Has Been Awarded A Royal Academy Of Engineering Enterprise Fellowship The support offered by the Royal Academy of Engineering Enterprise Fellowship will enable Ruizhi to further establish and grow HexagonFab which is developing next-generation...
Abselion is delighted to announce the appointment of Kim Orton-Smith as Vice President of Sales & Marketing.
The last few years have been nothing short of amazing – together, we have achieved remarkable milestones that we can all be incredibly proud of.
The Bolt is an analytical lab instrument to speed discovery and production of next-generation biopharmaceuticals.
A warm welcome to our new board members, Dr Oliver Hardick of M Ventures and Chris Major of BioProcess 360 Partners.
At ELRIG Drug Discovery 2021, HexagonFab received the Innovation AveNEW top startup company award from SLAS!
Last week we presented our solution for next generation medical sensing to a panel of experts at AMS, a world-leader in automotive, wearable and medical sensing. The presentation took place during the Health Tech Hub 2020 event in Graz. HexagonFab was selected as the...